Promising results for Atrial Fibrillation | UnityPoint Health
A new treatment at Unity Point Health is offering promising results for those with irregular heartbeats, otherwise known as ...
Doylestown Health Expands Treatment Options For Atrial Fibrillation
DOYLESTOWN, PA — Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary ...
Rolling Out1d
8 alarming signs young adults face higher A-fib risks now
Research reveals rise in AFib among younger people. Learn the warning signs, risk factors and how to protect your heart ...
Rolling Out1d
Breakthrough treatment offers new hope for A-fib patients
Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.
Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...
medtechdive8h
Doctors expect Boston Scientific to lead PFA race, survey finds
Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
Hometown Source1d
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent atrial fibrillation
Allina Health Minneapolis Heart Institute first in Minn., Upper Midwest to use new, FDA-approved device to treat persistent ...
Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client
DelveInsight, a leader in pharma consulting services, conducted an Asset Prioritization Analysis for a pharmaceutical client ...
A majority of smartwatch users are making a critical mistake
As per a survey, only a fraction of smartwatch users share details of their health stats with a doctor, a misstep that could ...
Science Daily4d
Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Medindia3d
New Blood Thinner Reduces Bleeding Risk in Atrial Fibrillation Patients
Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than standard anticoagulants.